Our Team

We are a team of entrepreneurs, scientists, researchers and tech developers who are all passionate about bringing innovation in digital health to patients.

We have built Dopavision to develop breakthrough healthcare solutions using digital technology. Our team combines scientific and technical curiosity with the goal of creating significant benefits for patients and users. Our offices are located in the heart of Berlin.

FOUNDING AND Management Team

Dr. Hamed Bahmani


Dr. Mark Wuttke

Chief Executive Officer

Dr. Andreas Balser

Chief Technology Officer

Dr. Gabriela Burian

Chief Medical Officer

Gabriela is a trained physician and epidemiologist. She is passionate about turning innovative ideas into new medical therapies that have practical applications for many patients by combining medical science and scientific methodology to achieve improved patient clinical care. She has expertise in biomedical and clinical research of new therapies in the field of ophthalmology, retina, which she acquired in academia, the pharmaceutical and biotechnology industry, and as an independent medical strategy advisor.

Dr. Jens Ellrich

Chief Scientific Officer

Advisory board members and observers

Dr. Dirk Sauer

Board Chair


Dr. Annegret de Baey-Diepolder

Venture Partner

Seventure Partners

Dr. Oliver Reuß​

Executive Director, Investment Manager

Boehringer Ingelheim Venture Fund

Dr. Rana Lonnen

Managing Director, dRx Capital


Christian Lautner



Stefan Zundel




Seventure Partners


Boehringer Ingelheim Venture Fund



Does Dopavision sound exciting to you? We are looking for talented people to join our team and help us bring our vision to life.

Does your profile not match? Nevertheless, does Dopavision sound exciting to you?
If so, please reach out to us with your profile at

Reach us

Dopavision GmbH
Pfuelstraße 5 (Aufgang V)
10997 Berlin

Our Partners

Dopavision is funded as part of the BMBF’s Industry-in-Clinic Platform Program (FKZ: 13GW0625)